Rituximab in the Treatment of Refractory Follicular Lymphoma - Six Doses Are Better Than Four
Author:
Affiliation:
1. Research Unit in Oncology Diseases, National Medical Center, IMSS, México, D.F. Mexico
2. Department of Hematology, Oncology Hospital, National Medical Center, IMSS, México, D.F. Mexico
Publisher
Mary Ann Liebert Inc
Subject
Hematology,Immunology
Link
https://www.liebertpub.com/doi/pdf/10.1089/15258160151135088
Reference8 articles.
1. Monoclonal antibody-based therapies for hematologic malignancies.
2. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma
3. IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
4. IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
5. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP;Blood;2022-01-20
2. The preclinical discovery of rituximab for the treatment of non-Hodgkin’s lymphoma;Expert Opinion on Drug Discovery;2015-06-17
3. Cancer Immunotherapy;Cancer Biotherapy and Radiopharmaceuticals;2011-02
4. Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma;British Journal of Clinical Pharmacology;2009-10
5. Biological therapy of B and T cell lymphoproliferative disorders;Principles of Cancer Biotherapy;2009
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3